-+ 0.00%
-+ 0.00%
-+ 0.00%

NetraMark appoints Abivax regulatory chief Keith Fournier to board

PUBT·09/01/2026 11:02:12
Listen to the news
NetraMark appoints Abivax regulatory chief Keith Fournier to board
  • NetraMark appointed pharmaceutical executive Dr. Keith M. Fournier to its board.
  • Fournier is senior vice president and head of regulatory affairs at Abivax.
  • He previously led global regulatory affairs at EMD Serono, Merck KGaA’s healthcare business.
  • Earlier roles included senior leadership posts at AbbVie, spanning oncology asset strategy and immunology regulatory affairs.
  • Fournier also served as a global regulatory lead at MedImmune, an AstraZeneca unit.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NetraMark Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609010700PRIMZONEFULLFEED9819186) on September 01, 2026, and is solely responsible for the information contained therein.